$865 Million is the total value of Boxer Capital, LLC's 23 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 29.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | Buy | MIRATI THERAPEUTICS INC | $125,751,000 | +89.4% | 1,715,560 | +9.6% | 14.54% | +77.2% |
| BGNE | BEIGENE LTDsponsored adr | $118,800,000 | -5.9% | 900,000 | 0.0% | 13.74% | -11.9% | |
| IMMU | Buy | IMMUNOMEDICS INC | $78,761,000 | +379.9% | 4,100,000 | +256.5% | 9.11% | +349.1% |
| ODT | ODONATE THERAPEUTICS INC | $65,860,000 | +57.0% | 2,978,762 | 0.0% | 7.62% | +47.0% | |
| QURE | Sell | UNIQURE NV | $56,668,000 | +63.9% | 950,000 | -20.8% | 6.55% | +53.4% |
| BIIB | New | BIOGEN INC | $47,276,000 | – | 200,000 | +100.0% | 5.47% | – |
| GOSS | New | GOSSAMER BIO INC | $40,631,000 | – | 1,875,000 | +100.0% | 4.70% | – |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $39,146,000 | -29.1% | 975,000 | -18.8% | 4.53% | -33.6% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $38,850,000 | -44.0% | 1,000,000 | -39.4% | 4.49% | -47.6% |
| PTCT | Sell | PTC THERAPEUTICS INC | $37,640,000 | -49.1% | 1,000,000 | -53.6% | 4.35% | -52.4% |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $32,382,000 | +12.1% | 4,200,000 | -6.7% | 3.74% | +4.9% |
| ALLK | New | ALLAKOS INC | $32,360,000 | – | 799,000 | +100.0% | 3.74% | – |
| SLDB | Sell | SOLID BIOSCIENCES INC | $31,954,000 | -65.9% | 3,473,272 | -0.7% | 3.70% | -68.1% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $25,715,000 | -11.7% | 1,466,051 | -25.4% | 2.97% | -17.4% |
| MDCO | Buy | MEDICINES CO | $16,770,000 | +277.7% | 600,000 | +158.6% | 1.94% | +253.2% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $16,600,000 | +0.7% | 1,250,000 | -40.3% | 1.92% | -5.7% |
| KURA | KURA ONCOLOGY INC | $14,015,000 | +18.2% | 844,789 | 0.0% | 1.62% | +10.6% | |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $13,233,000 | -53.9% | 250,000 | -64.3% | 1.53% | -56.9% |
| MTNB | Buy | MATINAS BIOPHARMA HLDGS INC | $11,105,000 | +230.7% | 10,188,312 | +80.6% | 1.28% | +209.4% |
| MEIP | MEI PHARMA INC | $8,943,000 | +16.3% | 2,913,091 | 0.0% | 1.03% | +8.8% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $5,724,000 | +44.9% | 200,000 | 0.0% | 0.66% | +35.7% | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $5,248,000 | -35.7% | 290,577 | 0.0% | 0.61% | -39.8% | |
| NVUS | NOVUS THERAPEUTICS INC | $1,304,000 | +151.3% | 324,383 | 0.0% | 0.15% | +135.9% | |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -50,000 | -100.0% | -0.35% | – |
| Exit | ESPERION THERAPEUTICS INC NEcall | $0 | – | -100,000 | -100.0% | -0.57% | – | |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -1,500,000 | -100.0% | -2.52% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -600,000 | -100.0% | -7.47% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
| BEIGENE LTD | 31 | Q3 2023 | 15.6% |
| KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
| ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
| DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
| ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
| ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
| SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
| iTeos Therapeutics, Inc. | May 11, 2022 | 2,154,058 | 6.1% |
| Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
| Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
| Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
| CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
| DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
| Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| SC 13D/A | 2024-02-08 |
| 4 | 2024-01-25 |
| SC 13D/A | 2024-01-25 |
| SC 13G | 2024-01-18 |
| SC 13D/A | 2023-12-18 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.